设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
Elsevier电子期刊(3)
在“
Elsevier电子期刊
”中,
命中:
3
条,耗时:小于0.01 秒
在所有数据库中总计命中:
3
条
1.
Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America
作者:
Luis E. Raez
1
;
2
;
lraez@mhs.net
;
Edgardo S. Santos
3
;
Christian Rolfo
4
;
Gilberto Lopes
5
;
Carlos Barrios
6
;
Andres Cardona
7
;
Luis A. Mas
8
;
Oscar Arrieta
9
;
Eduardo
Richardet
10
;
Carlos Vallejos S
11
;
Ignacio Wistuba
12
;
David Gandara
13
;
Fred R. Hirsch
14
关键词:
ALK
;
EGFR
;
Molecular markers
;
Screening
;
Targeted therapy
刊名:Clinical Lung Cancer
出版年:2017
2.
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial
作者:
John C Araujo
;
G茅ralyn C Trudel
;
Fred Saad
;
Andrew J Armstrong
;
Evan Y Yu
;
Joaquim Bellmunt
;
George Wilding
;
John McCaffrey
;
Sergio V Serrano
;
Vsevolod B Matveev
;
Eleni Efstathiou
;
Stephane Oudard
;
Michael J Morris
;
Bruce Sizer
;
Peter J Goebell
;
Axel Heidenreich
;
Johann S de Bono
;
Stephen Begbie
;
Jun H Hong
;
Eduardo
Richardet
;
et al.
刊名:Lancet Oncology
出版年:December, 2013
3.
Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer
作者:
Jose R. Pereira
;
Luis Fein
;
Auro del Giglio
;
Cé
;
sar R. Blajman
;
Eduardo
Richardet
;
Gilberto Schwartsmann
;
Mauro Orl
o ;
Belinda J. Hall
;
Teena M. West
;
Maximiliano van Kooten
关键词:
Non-small cell lung cancer
;
Fixed dose rate
;
Gemcitabine
;
Cisplatin
;
Chemotherapy
;
Randomised trial
刊名:Lung Cancer
出版年:2007
1
按检索点细分(3)
作者(3)
按出版年细分(3)
2027年及以后(1)
2017年(1)
2007年(1)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.